The UK's Defence and Science Technology Laboratory (DSTL) has developed a new diagnostic test for the Ebola virus which is said to offer significant advantages over the current testing method. [ + ]

Regeneus (ASX:RGS) has completed the manufacture of its off-the-shelf allogeneic stem cell therapy product, Progenza, for a human trial for the treatment of osteoarthritis (OA). This marks the first time Progenza has been produced at scale for use in a human trial.

Researchers have revealed the presence of two antibodies in a subgroup of children experiencing their first episode of psychosis, affirming a longstanding recognition that autoimmune disorders play a significant role in psychiatric illness.

An international research team, led by the University of Melbourne, has sequenced the genetic code of the roundworm Toxocara canis.

Scientists at the University of Central Florida have developed a prostate cancer test that is said to be faster, cheaper, more sensitive and more accurate than the standard PSA test for early-stage prostate cancer. [ + ]

Tel Aviv University researchers have developed the ability to turn smartphones into powerful hyperspectral sensors, capable of identifying the chemical components of objects from a distance. [ + ]

Monash University has opened its Green Chemical Futures building - a multidisciplinary innovation hub dedicated to supporting Australia's academic and industrial research within the chemicals manufacturing sector. [ + ]

In spite of large-scale deforestation in the tropics, vegetation has increased by almost the equivalent of 4 billion tonnes of carbon since 2003.

A study led by Sydney's Garvan Institute of Medical Research has revealed a new discovery regarding triple-negative breast cancers (TNBCs) - cancers which lack any of the three receptors (oestrogen, progesterone or HER2) that would make them responsive to targeted drugs.

Setaram Instrumentation has announced DKSH Australia as its new exclusive representative in Australia and New Zealand. [ + ]

Molecular diagnostics company Genetic Signatures listed on the ASX today under the stock code 'GSS', following a successful IPO which achieved the maximum raising of $7.5 million. [ + ]

The Professional Standards Councils (PSC) will fund a year-long study to identify the skills and qualities required to successfully put research to use via commercialisation. [ + ]

In order to encourage leadership at an internationally competitive level, the National Health and Medical has recognised four Australian health centres as NHMRC Advanced Health Research and Translation Centres. [ + ]

An international research team has suggested that the ingestion of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), long associated with lowering the risk of bowel (colorectal) cancer, may be dependent on a person's individual genetics. [ + ]

An international research team has suggested that the ingestion of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), long associated with lowering the risk of bowel (colorectal) cancer, may be dependent on a person's individual genetics. [ + ]